California Public Employees Retirement System’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

California Public Employees Retirement System’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-37,339	Closed	-$4.01M	–	1213
2023 Q1	$4.01M	Buy	+37,339	New	+$4.3M	﹤0.01%	1123

Other funds holding RXDX

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

California Public Employees Retirement System's RXDX Position: Q2 2023 in Review

California Public Employees Retirement System sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 37,339 shares — an estimated $4.01M sold.

California Public Employees Retirement System first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $4.01M in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

California Public Employees Retirement System reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
California Public Employees Retirement System sold 37,339 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $4.01M.
California Public Employees Retirement System first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
California Public Employees Retirement System's Prometheus Biosciences, Inc. Common Stock position peaked at $4.01M in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on California Public Employees Retirement System's 13F filing for Q2 2023, filed 9 Aug 2023.